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Abstract; 24	
 25	
Study Hypothesis: Can the activity of the IκB kinase (IKKβ) complex in endometriotic cells 26	
contribute to endometriotic lesion survival? 27	
Study answer: There is a constitutive activity of the IKKβ catalytic complex in peritoneal 28	
and deeply infiltrating lesions that can influence epithelial, but not stromal cell viability. 29	
What is known already: Endometriotic lesions exist in an inflammatory microenvironment 30	
with higher local concentrations of cytokines, such as tumor necrosis factor α (TNFα). TNFα 31	
stimulates the activation of the IKKβ complex, an important nodal point in multiple signalling 32	
pathways that influence gene transcription, proliferation and apoptosis. However, few data on 33	
the regulation of IKKβ in endometriotic tissue are currently available.  34	
Study Design, size, duration: A retrospective analysis of endometriotic tissue from 35	
peritoneal, ovarian and deeply infiltrating lesions from 37 women.  36	
Participants/materials, setting, methods: Basal and activated (phosphorylated) IKKβ 37	
concentrations were analysed by Western blotting and immunohistochemistry. The 38	
relationship between the expression and activation of these proteins and peritoneal fluid 39	
(TNFα) concentrations, measured via ELISA, was examined. A subsequent in vitro analysis 40	
of TNFα treatment on the activation of IKKβ and the effect on epithelial and stromal cell 41	
viability by its inhibition with PS1145 was also performed. 42	
Main results and role of chance; Levels of the phosphorylated IKKβ complex in 43	
endometriotic lesions had a significant positive correlation with peritoneal fluid TNFα 44	
concentrations. Phosphorylated IKKβ complex was more prevalent in peritoneal and DIE 45	
lesions compared to ovarian lesions. IKKβ was present in both epithelial and stromal cells in 46	
all lesions but active IKKβ was limited to epithelial cells. TNFα stimulated an increased 47	
expression of phosphorylated IKKβ and the inhibition of this kinase with PS1145 48	
significantly influenced ectopic epithelial cells viability but not eutopic epithelial cells, or 49	
endometrial stromal cells. 50	
Limitations, reasons for caution; In vitro analysis on epithelial cells was performed with 51	
immortalized cell lines and not primary cell cultures and only low sample numbers were 52	
available for the study. 53	
Wider implications of the findings; The regulation of aberrant signalling pathways 54	
represents a promising yet relatively unexplored area of endometriosis progression. The IKKβ 55	
complex is activated by inflammation and is critical nodal point of numerous downstream 56	
kinase-signalling pathways, including NFκB, mTOR and BAD. This study shows a 57	
significant relationship between peritoneal fluid TNFα and IKKβ activation in epithelial cells 58	
that will have significant consequences for the continued survival of these cells at ectopic 59	
locations through the regulation of downstream pathways. 60	
Large scale data: none 61	
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Introduction 69	
Endometriosis is characterized by the growth of endometrial epithelial and stromal cells 70	
outside the uterine cavity. It is an extremely prevalent disease occurring in 10-20 % of women 71	
of reproductive age and is accompanied by chronic pelvic pain and subfertility. Although the 72	
exact pathogenesis is not yet clear Sampson’s theory of transplantation is commonly accepted 73	
(Sampson, 1928). This theory proposes that viable endometrial epithelial and stromal cells are 74	
refluxed back through the Fallopian tube into the peritoneal cavity during menstruation. Once 75	
in this ectopic environment these cells avoid immune detection, invade the underlying 76	
mesothelial layer and stimulate a chronic inflammatory response. 77	
 78	
Numerous inflammatory cytokines and chemokines (Borrelli et al., 2013; 2014) are increased 79	
in the peritoneal fluid of women with endometriosis, which occurs through the coordinated 80	
interaction of the refluxed endometrial and peritoneal immune cells. Refluxed endometrial 81	
cells produce and secrete chemokines (Hornung et al., 1997) that attract leukocytes and 82	
activated peritoneal macrophages (Halme et al., 1983). The activated macrophages produce 83	
inflammatory cytokines, which in turn further stimulate cytokine production by the 84	
endometrial cells, creating a feed forward regulatory loop (Lebovic et al., 2001) and the 85	
chronic inflammatory environment. This inflammatory environment has the potential to both 86	
influence symptomology (McKinnon et al., 2015) and disease progression (Bruner-Tran et 87	
al., 2013).  88	
 89	
A chronic inflammatory environment can contribute to endometriotic lesion progression 90	
through the activation of a series of intracellular kinase signalling pathways (McKinnon et al., 91	
2016). The IκB kinase (IKK) complex represents a significant, early nodal point in many of 92	
the kinase signalling pathways. In the nuclear factor (NF)κB signalling pathway the IKK 93	
complex removes the inhibitory IκB protein from NFκB allowing translocation into the 94	
nucleus and gene transcription (Bonizzi and Karin, 2004) subsequently influencing the gene 95	
expression of many cytokine and chemokines, immunoreceptors, cell adhesion molecules, 96	
stress response genes, and growth factors (Pahl, 1999). IKKβ also interacts with the tubular 97	
sclerosis (TSC2) protein in the mammalian target of rapamycin (mTOR) pathway influencing 98	
cellular proliferation (Lee et al., 2007) and phosphorylates Bcl2-antagonist of cell death 99	
(BAD) pathway suppressing apoptosis (Yan et al., 2013).   100	
 101	
The IKKβ complex consists of two catalytic subunits, IKKα and IKKβ and one regulatory 102	
subunit (IKKγ) (Hinz and Scheidereit, 2014). The binding of extracellular tumor necrosis 103	
factor (TNF)α to its cell membrane receptor TNFR (Haider and Knöfler, 2009) stimulates the 104	
phosphorylation of both IKKα and IKKβ and activation of the IKKβ complex. TNFα 105	
concentrations are increased in the peritoneal fluid of endometriosis (Harada et al., 1999) and 106	
are correlated with the severity of the disease (Bedaiwy et al., 2002) and thus TNFα 107	
stimulated IKKβ activity may have a significant influence on the endometriotic  lesions. 108	
 109	
At present very little information is available on the expression and activity of this important 110	
upstream nodal kinase in endometriotic cells. In this study we used a combination of clinical 111	
and in vitro experiments to determine the presence and importance of IKKβ in endometriosis. 112	
We found that peritoneal fluid TNFα concentrations had a significant positive correlation 113	
with the activated IKKβ complex and that this was most likely due to epithelial cell 114	
expression. Furthermore IKKβ activity was important in regulating ectopic epithelial cell, but 115	
not stromal cell survival. These results therefore suggest a significant role of IKKβ in 116	
endometriotic epithelial cells that deserves further attention.  117	
Methods; 118	
Patient samples 119	
Prior to surgery the relevant institutional review board granted ethical approval and informed 120	
consent was obtained from all patients. During surgery performed for suspected 121	
endometriosis samples of endometrium, peritoneal fluid and endometriotic lesions were 122	
collected. Endometrial biopsies were collected via soft curette (Pipelle de Cornier, 123	
Laboratoire CCD, France) and stored in RNAlater (Thermo Fischer Scientific, USA) at -80 124	
°C as described previously (Santi et al., 2011). Peritoneal fluid was collected during the 125	
laparoscopic procedure from the cul-de-sac and centrifuged to remove blood cells, aggregates 126	
and debris. Samples were excluded if blood remained in the samples. The pelvic cavity was 127	
examined and any endometriotic lesions were removed and the patient staged (no 128	
endometriosis, or stage I-IV) according to the revised American Fertility Society staging 129	
system (rAFS) (“Revised American Society for Reproductive Medicine classification of 130	
endometriosis,” 1997). The lesions were recorded as either peritoneal, ovarian or deeply 131	
infiltrating endometriosis (DIE). All surgeries were performed during the proliferative phase 132	
of the menstrual cycle and endometriosis was confirmed by histological analysis. 133	
 134	
Endometrial biopsies were collected from both women with (n = 8) and without 135	
endometriosis (n = 7) and used for the isolation of primary cells via collagenase digestion and 136	
size exclusion, as described previously (McKinnon et al., 2012). Strong yields were obtained 137	
for the primary stromal cells (ESC) from all women except one without endometriosis, 138	
however only limited amounts of epithelial cells could be successfully isolated.  As 139	
endometrial epithelial cells are terminally differentiated and do not propagate immortalized 140	
epithelial cells were acquired. Matching peritoneal fluid of sufficient quality was not always 141	
available for cytokine measurement therefore if peritoneal fluid was available the ectopic 142	
lesions were immediately frozen and stored for stored fresh frozen for subsequent Western 143	
blot analysis. If peritoneal fluid was not available, they were formalin fixed and paraffin 144	
embedded for immunohistochemistry analysis. 145	
 146	
Cytokine measurement in peritoneal fluid 147	
TNFα was measured by an enzyme-linked immunoabsorbent assay (ELISA) kit (R&D 148	
Systems, Abingdon, England) using a high-sensitivity NADH cascade amplified alkaline 149	
phosphatase with antigen-antibody incubations at 28 °C in a dry incubator and at a dilution of 150	
1:2 in the diluent provided. Peritoneal fluid progesterone concentrations were also measured 151	
via a radioimmunoassay (Coata-count, DPC; Buhlmann Laboratories, Allschwil, Switzerland) 152	
to confirm the patient cycle phase (McKinnon et al., 2014).  153	
 154	
Protein isolation and Quantification in ectopic lesions 155	
Approximately 30mg of fresh frozen ectopic tissue was used to prepare whole cell extracts 156	
via homogenization with the FastPrep 120 tissue homogenizer (30 seconds at 4.0 m/s) in 157	
radioimmunoprecipitation assay buffer (RIPA; 50mM Tris-Cl, pH 7.4, 150mM NaCl, 1mM 158	
EDTA, 1% v/v triton X-100, 1 % w/v sodium deoxycholate, 0.1% w/v sodium dodecyl sulfate 159	
and 1% v/v protease and phosphatase inhibitor cocktail (Cell Signalling Technology, 160	
Danvers, Massachusetts)). Final protein concentrations were determined by the bicinchoninic 161	
acid assay (QuantiPro BCA; Sigma). 162	
 163	
Proteins separation was performed by heating 20µg of total protein into LDS buffer 164	
(Invitrogen) to 70 °C for 10 minutes and running it on a 4 -15 % Novex NuPAGE Bis/Tris gel 165	
(Invitrogen). Proteins were transferred to a 0.45µm nitrocellulose membrane in 4-166	
morpholinepropanesulfonic acid buffer (MOPS; Invitrogen) pH 7.7 for 1 hour. Non-specific 167	
binding was blocked by incubation with 5% bovine serum albumin (BSA) in phosphate 168	
buffered saline (PBS) containing 0.1% Tween 20 (PBST).  Membranes were probed with 169	
rabbit anti-IKKβ antibody (1:1000) (Cell Signalling Technology), and with rabbit anti-170	
pIKKα/β(176/180)(1:1000) antibody (Cell Signaling Technology), or mouse anti-actinβ 171	
antibody (Abcam, Cambridge, UK) 1:5000. Secondary anti-rabbit (GE Healthcare, Opfikon, 172	
Switzerland) and anti-mouse (Sigma) antibodies conjugated to horseradish perioxidase were 173	
diluted 1:50 000 and 1:200 000 respectively. Immuno-reactivity was determined with the 174	
SuperSignal West Femto kit (Pierce; Thermo Scientific) using the Chemi-Doc XRS+ system 175	
(Bio-Rad Laboratories, AG, Cressier, Swituzerland). Band densitometry was quantified with 176	
the Quantity One software and in each Western blot a calibrator sample with strong IKKβ, 177	
and pIKKα/β expression was included to normalize concentrations across gels and determine 178	
protein concentrations relative to the calibrator sample. The relative expression of each 179	
sample was expressed as a percentage of the calibrator. Actinβ was used as a loading control. 180	
 181	
Immunohistochemistry 182	
Immunohisotchemistry was performed using serial sections of 4µm mounted onto glass slides 183	
(Superfrost, Braunschweig, Germany), dewaxed in xylene and rehydrated through a series of 184	
decreasing ethanol concentrations. Epitope retrieval was performed with 10mM citrate buffer, 185	
pH 5.5 for 5 minutes in a 450W microwave. Endogenous perioxidase activity was blocked 186	
with 3% hydrogen perioxide (H2O2) and a blocking step performed with 3% BSA for 30 187	
minutes in Tris buffered saline (TBS; Tris 100mM, NaCl 0.15 M; pH 7.4). Rabbit anti-IKKβ 188	
antibody (1:100) and rabbit anti-pIKKα/β (176/180) antibody (1:100) were diluted in 3% 189	
BSA in TBS and incubated at 4 °C overnight in a humidified chamber. Slides were washed 190	
with TBS and 0.1% Tween 20 (TBST) prior to incubation with an affinity purified, biotin 191	
conjugated goat anti-rabbit antibody (Dako, Glastrup, Denmark) for 90 minutes at room 192	
temperature. After a final wash slides were incubated with an avidin-biotin HRP complex 193	
(Vectastain, ABC Kit, Vector Laboratories, Burlingham, CA, USA) for 45 minutes. The 194	
antigen-antibody complex was detected by incubation with 3,3’ diaminobenzidine substrate 195	
and slides were counterstained with hematoxylin and mounted in Aquatex (Merck). The 196	
primary antibodies were excluded for the negative controls. Images were photographed with a 197	
Nikon Eclipse E800 microscope (Nikon, Japan). Semi-quantitative analysis of antibody 198	
staining in the epithelial and stromal cells of the endometriotic lesions was determined by the 199	
allocation of scores between 0-3; 0 (negative), 1 (weak), 2 (moderate) and 3 (strong), based 200	
on the intensity of staining. The percentage of cells with positive immuno-reactivity was also 201	
determined and allocated a score between 0-6 as described 0% = 0, 1-10% = 1, 11-30% = 2, 202	
31-50% = 3, 51-70% = 4, 71-90% = 5; > 91% = 6 in each cell type of the endometriotic 203	
lesions. For the final immuno-reactive score the staining intensity and percentage of positive 204	
cells was multiplied, as described previously (Samartzis et al., 2012). 205	
 206	
Cell culture and TNFα treatment 207	
Isolated primary endometrial stromal cells (ESC) were maintained in Iscoves’s modified 208	
Eagle medium (IMEM) (Invitrogen) supplemented with 10% fetal calf serum (FCS) 209	
(Invitrogen) and 1% antibiotic/antimycotic (Invitrogen). The immortalized epithelial cell 210	
lines, EM E6/E7 and EM’osis, were provided by Professor Kyo, Kanazawa, Japan and were 211	
isolated from eutopic endometrium (Kyo et al., 2003) and an ectopic endometrioma (Bono et 212	
al., 2012) respectively. These cells were maintained in Dulbecco’s modified Eagles medium 213	
(DMEM) (Invitrogen) with 10% FCS and 1% antibiotic/antimycotic. The 12Z cells were 214	
provided by Professor Starzinski-Powitz, Goethe University and were originally isolated from 215	
a peritoneal endometriotic lesion (Zeitvogel et al., 2001). These cells were also maintained in 216	
complete DMEM media.  217	
To determine the influence of TNFα on pIKKα/β activity in all cell types the cells were 218	
seeded into 6 well plates at approximately 3 x105 cells/ well. After reaching approximately 219	
80% confluence the media was changed to 0.5% FCS for overnight incubation prior to 220	
treatment. Cells were treated either with control media (0.5% FCS in normal media) or 221	
control media plus 10ng/ml and 100ng/ml recombinant human TNFα (R&D systems, United 222	
Kingdom) for 6 hours. At the end of the treatment period the cells were rinsed and collected 223	
in RIPA buffer. 224	
 225	
MTS assay and treatment with PS1145 226	
PS1145 is a small molecular weight compound that is a specific inhibitor of IKKβ activity 227	
(Lam et al., 2005). Inhibition of IKKβ activity with PS1145 was performed in 96 well plates 228	
seeded at a density of 6x103/ well. Twenty-four hours prior to treatment the cells were 229	
changed into serum free media and treatment media prepared by diluting PS1145 into either 230	
serum free media at a final concentration of 1µM.  Subsequent concentrations were prepared 231	
by a 1:3 serial dilution (333.33nM, 111.11nM, 37.04nM, 12.3nM & 4.12nM). Cell viability 232	
was measured after 72 hours by the CellTiter 96 Aqueous One Solution Cell Proliferation 233	
Assay (Promega). Triplicate wells were used for each cell type and experiment. For the 234	
immortalized epithelial cell lines the experiment was repeated three times and for the primary 235	
ESC an experiment on each of the eight endometriosis and seven non-endometriosis 236	
preparations was performed separately. A control (without PS1145) was included for each 237	
experiment and designated as 100% viability and subsequent values expressed as a percent of 238	
control. 239	
 240	
Statistical Analysis; 241	
All statistical analyses were performed with Graphpad Prism version 6.0. The correlation 242	
between the peritoneal fluid cytokines and IKKβ and pIKKα/β expression was performed 243	
using the non-parametric Spearman’s rank correlation coefficient. Two groups comparisons 244	
were performed with a non-parametric Mann-Whitney U test and the comparison of three or 245	
more groups with the non-parametric Kruskal-Wallis One-way analysis (ANOVA) and 246	
Dunn’s multiple comparison Post hoc test. The interaction between two variables was 247	
determined via a two-way ANOVA with a post-hoc Tukey’s multiple comparison test to 248	
determine the difference between individual groups or conditions.  249	
  250	
Results; 251	
Patient data and characteristics 252	
In total, endometriotic tissue was removed from 37 endometriosis patients and endometrial 253	
biopsies from eight women without endometriosis. Of these 37 women we collected 254	
accompanying peritoneal fluid from 21 in order to compare peritoneal fluid TNFα and ectopic 255	
IKKβ. Of the 21 samples 14 were collected from women without any hormonal treatment, 256	
four were using combined oral contraceptives (COC) and three were using GnRH analogues. 257	
No significant variation in TNFα, IKKβ or pIKKα/β based on hormonal use (Table 1) was 258	
identified. Five of the lesions were peritoneal, eleven ovarian and five DIE.  259	
 260	
The remaining 16 samples without accompanying peritoneal fluid were kept for 261	
immunohistochemistry. Of these, six women had no history of hormonal treatment, five were 262	
using COC and five were using GnRH analogues. Three lesions were peritoneal, seven 263	
ovarian and six DIE. No significant variation was observed between either pIKKα/β, or IKKβ 264	
expression in both the epithelial and stromal cells based on hormonal treatment (Table II). 265	
 266	
IKKβ expression and activation in endometriotic tissue and its relationship to peritoneal 267	
fluid TNFα concentrations; 268	
Comparison of peritoneal fluid TNFα and endometriotic lesion IKKβ and pIKKα/β showed a 269	
significant positive correlation between TNFα and pIKKα/β (r = 0.6268, n = 21, p = 0.0024) 270	
(Figure 1A), but not IKKβ (r = 0.4216, n = 21, p 0.0570) (Figure 1B), as determined by semi 271	
quantitative Western blot (Figure 1C). A significant variation in pIKKα/β concentrations 272	
between lesions from different locations (p < 0.05) was observed with a post-hoc analysis 273	
confirming a significantly lower expression in ovarian lesions (50  ± 8.7, n =11) compared to 274	
the peritoneal lesions (99 ± 9.7, n =5) (p = 0.041) (Figure 1D). No significant difference was 275	
observed with the DIE lesions (91 ± 21.6, n = 5). In contrast, IKKβ expression showed no 276	
variation between lesion types (p = 0.4905) with similar expression in the peritoneal (138 ± 277	
29.3, n = 5), ovarian (128 ± 26.7, n = 11) and DIE lesions (80 ± 26.9, n = 5) (Figure 1E). The 278	
active to inactive ratio of IKKβ (pIKKα/β:IKKβ) varied significantly between lesions (p = 279	
0.0123) with both peritoneal (1.0 ± 0.39, n = 5) and DIE (1.7 ± 0.54, n =5) higher than 280	
ovarian lesions (0.5 ± 0.09, n = 11) with a post-hoc analysis showing a significant difference 281	
between DIE and ovarian lesions (p = 0.0168).   282	
 283	
Cell specific activation of IKK in endometriotic lesions 284	
Immunohistochemistry identified a low but uniform expression of IKKβ in peritoneal (Figure 285	
2A), ovarian (Figure 2B) and DIE lesions (Figure 2C) in both stromal (red arrows) and 286	
epithelial cells (black arrows). In contrast, pIKKα/β in peritoneal (Figure 2D), ovarian 287	
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(Figure 2E) and DIE (Figure 2F) lesions was predominantly epithelial (black arrows), with 288	
significantly less stromal cells expression (red arrows). Negative controls showed no 289	
expression in peritoneal (Figure 2G), ovarian (Figure 2H), or DIE (Figure 2I) lesions. No 290	
statistically significant difference was observed in IKKβ expression between either lesion 291	
location (p = 0.2420) or cell type (p = 0.1972) (Figure 2J), although this could be due to a 292	
lack of power. pIKKα/β expression was significantly different in cell types (p = 0.0198), but 293	
no statistically significant difference could be observed between lesion type (p = 0.3402) 294	
(Figure 2K)possibly again due to lack of power.  295	
 296	
IKKβ activity after TNFα treatment 297	
 298	
Western blot analysis of pIKKα/β after TNFα treatment of epithelial cell cultures confirmed a 299	
low but positive expression in all cell lines examined (Figure 3A). Semi-quantitation of band 300	
densitometry indicated that the 12Z cells showed the strongest basal expression (no TNFα), 301	
but this did not vary after TNFα treatment (p = 0.2320). The EM’E6/E7 cells showed lower 302	
basal expression and also no significant variation after TNFα treatment (p = 0.4475). In 303	
contrast, TNFα treatment of EM’osis cells significantly increased pIKKα/β above the no 304	
treatment control (46 ± 5.0, n = 3) at concentrations of both 10ng/ml (141 ± 34.2, n = 3, p = 305	
0.0173) and 100ng/ml (197 ± 23.3, n = 3, p = 0.0085) (Figure 3B). Similar Western blots 306	
were performed on protein lysate isolated from stromal cells however no protein expression 307	
could be observed in these preparations. 308	
 309	
Cell specific influence of IKKβ inhibition on viability  310	
 311	
In the epithelial cell cultures there was a significant influence of PS1145 on cell viability 312	
based on cell type (p < 0.0001) (Figure 4A). No significant effect of PS1145 was observed on 313	
the EM E6/E7 at any concentration. For EM’osis cells there was a significant increase in cell 314	
viability at the lowest concentrations (PS1145 2.43nM; 123 ± 0.2, n = 3, p < 0.001) that was 315	
gradually diminished as concentrations increased (PS1145 1µm; 106 ± 6.3 p > 0.05), whereas 316	
12Z cell viability was significantly decreased at the lowest concentrations (PS1145 2.43nM; 317	
70 ± 4.6, n = 3, p < 0.0001) and remained significantly reduced through to the highest 318	
concentration (PS1145 1µm; 73 ± 2.6, n = 3, P < 0.0001). In contrast primary ESC isolated 319	
from women with and without endometriosis showed no significant variation based on either 320	
PS1145 (p = 0.8868) or cell type (p = 0.3516) (Figure 4B). 321	
 322	
 323	324	
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Discussion 325	
 326	
In this study we examined the expression of the IKKβ protein kinase complex and the 327	
activation of its catalytic subunits pIKKα/β in both endometriotic lesions, as well as its 328	
influence on cell survival in in vitro models. The results show a significant relationship 329	
between the phosphorylation of the IKKβ complex and peritoneal fluid TNFα. Subsequent 330	
immunohistochemistry staining showed that although no statistically significant difference in 331	
IKKβ expression was observed across all cells and lesion types the phosphorylated IKKβ 332	
complex was predominantly epithelial. This data was supported by the in vitro studies that 333	
confirmed pIKKα/β expression in epithelial cell culture models, but not primary stromal cells 334	
and that inhibition of IKKβ activity significantly influenced endometriotic epithelial cell 335	
viability, but not eutopic epithelial cell viability, nor the viability of endometrial stromal cells 336	
from women with and without endometriosis. These results therefore suggest that a 337	
dysregulation of the IKKβ kinase occurs in ectopic epithelial cells that may be related to the 338	
inflammatory microenvironment. Given the role of IKKβ in transmitting extracellular signals 339	
into cell survival via kinase signalling pathways it may represent a significant molecule in 340	
endometriosis pathogenesis. 341	
 342	
At present there is very little known about the role of IKKβ in endometriosis.  The results 343	
from our clinical samples suggest that the constitutive IKKβ activity is significantly different 344	
between peritoneal and DIE lesions compared to ovarian lesions. This difference of 345	
expression was supported by our in vitro results that showed TNFα stimulated an increase in 346	
pIKKα/β expression and that inhibition of IKKβ activity increased the Em’osis cell viability. 347	
In contrast in the peritoneal derived epithelia cells TNFα had a limited influence of pIKKα/β 348	
expression and inhibition of IKKβ activity decreased cell viability. Unfortunately a DIE 349	
derived cell line was not available.  350	
 351	
Endometriosis is a significantly heterogeneous condition, although whether these lesions have 352	
different pathologies (Nisolle and Donnez, 1997), or represent a continuum of the same 353	
disease (Somigliana et al., 2004) is still debated. These data suggest a varied cellular response 354	
to inflammation may occur in different lesions. It has previously been shown that rectovaginal 355	
septum lesions have a distinctly inflammatory phenotype (Bertschi et al., 2013) and that 356	
concentrations of inflammatory mediators are stronger in the peritoneal fluid of DIE 357	
compared to lesions from other locations (Santulli et al., 2012). As IKKβ can be associated 358	
with TNFα both in ours and other studies (Lee et al., 2007) it is possible that the increased 359	
production of inflammation associated with DIE lesions is related to the higher IKKβ activity.  360	
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The identification of a TNFα influenced activation of the IKKβ in endometriotic tissue is 361	
significant because of the multiple downstream pathways it regulates (Figure 5) and the 362	
influence this can have on gene transcription, protein translation and both cellular 363	
proliferation and apoptosis. Activation of IKKβ stimulates NFκB gene transcription and a 364	
constitutive activation of NFκB has been observed in peritoneal endometriosis (González-365	
Ramos et al., 2007). Multiple factors present in the peritoneal fluid of women with 366	
endometriosis including cytokines and iron overload (Alvarado-Díaz et al., 2015) may lead to 367	
this constitutive activation. Furthermore an increased NFκB activity has been linked to 368	
recurrence of ovarian endometrioma (Shen et al., 2008). Neither of these studies however 369	
examined IKKβ expression directly. In the immortalized epithelial 12Z cells IKKβ inhibition 370	
attenuated inflammatory cytokine secretion (Grund et al., 2008) and in ectopic endometrial 371	
stromal cells miR200a suppresses IKKβ (Dai et al., 2012), raising the possibility of 372	
suppressed IKKβ activity in stromal cells occurs via an epigenetic regulation. In contrast to its 373	
role in inflammation via the NFκB pathway, IKKβ can also regulate cellular proliferation and 374	
apoptosis through the mTOR and BAD pathways (Dunlop and Tee, 2014) (Yan et al., 2013). 375	
A dysregulation of mTOR has previously been implicated in endometriosis pathogenesis of 376	
DIE lesions leading to increased proliferation (Leconte et al., 2011), as has a role for mTOR 377	
mediated autophagy (Choi et al., 2014) and BAD activation in ovarian endometriomas 378	
(Stickles et al., 2015). Together this suggests that TNFα has the potential to modulate all of 379	
these activities via IKKβ activation. 380	
 381	
We found that the constitutive activation and influence on cell survival was largely restricted 382	
to epithelial cells. Endometriotic lesions are a combination of epithelial and stromal cells and 383	
an interdependency between the cells types is required for endometriotic lesions to continue 384	
proliferating as tissue integrity of refluxed endometrial matter is essential to endometrial 385	
tissue implantation (Nap et al., 2003). We have also previously shown that the stromal cells 386	
produce significantly more inflammatory cytokines than epithelial cells in response to 387	
stimulation (Bersinger et al., 2008). It could therefore be postulated that a paracrine 388	
regulation occurs in the lesions through the stromal cells production of cytokines stimulating 389	
a constitutive activation of the IKKβ complex in epithelial cells, which ultimately contributes 390	
to cell survival. More research however is required to explore this hypothesis.  391	
 392	
Furthermore, the activity of IKKβ in other cell types other than endometriotic cells was not 393	
directly addressed in this study, but may give further insight into this mechanism in normal 394	
tissue. For endometriosis, however whether this mechanism also happens in healthy eutopic 395	
epithelial cells may be of less consequence. This is because epithelial cells will only be 396	
present in the peritoneal cavity when endometriosis is present, and when endometriosis is 397	
present there is a constant inflammatory environment. We believe it is this confluence of 398	
ectopic epithelial cells and constant inflammation that makes the contribution of TNFα 399	
stimulated IKKβ activity significant. It may be such that this is a characteristic not inherent in 400	
the endometrium, but rather acquired during the life of the lesion and contribute more to 401	
progression through a constant stimulation of the inflammatory cascade. Further study on 402	
whether there is a significant difference between the activation of IKKβ in the eutopic 403	
endometrium of women with and without endometriosis would be an interesting follow-up.  404	
 405	
Whether other cell types also show a constitutive activity of IKKβ in the presence of 406	
inflammation would also be interesting. In this study the images in Figure 2 indicate cells 407	
proximal to the endometriotic lesion are largely negative for pIKKα/β expression, providing 408	
circumstantial evidence for the preferential activation of pIKKα/β in endometriotic epithelial 409	
cells. Previous studies suggest that cells proximal to the lesion may have different 410	
characteristics to cells distal to the lesions (Young et al., 2014) and these cells thus may also 411	
be interesting to study, however we were unable to collect this tissue due to our current 412	
ethical approvals. Future studies on this topic may however be warranted. 413	
 414	
Limitations of this study were the inclusion of women with hormonal treatment. Previous 415	
research however has suggested there was no significant influence on NFκB activation by 416	
oral contraceptives (González-Ramos et al., 2007). We also observed no statistically 417	
significant difference for IKKβ in this study, although the power of this analysis was limited 418	
by the small sample size. It is possible that this may introduce a variability in peritoneal fluid 419	
cytokine concentrations in endometriotic women, as GnRHa analogues have been shown to 420	
have an influence on the inflammatory environment (Nirgianakis et al., 2013), however we 421	
postulate that a reduction in inflammatory cytokines by hormonal treatment would also be 422	
reflected by a subsequent reduction in IKKβ activation, maintaining any correlation between 423	
the extra and intracellular environment. A further limitation of this study is the small sample 424	
size. An expansion of the sample number would provide more definitive information on both 425	
the influence of TNFα, as well as hormonal treatments, on IKKβ activity. It is difficult to 426	
draw direct conclusions on the contribution of IKKβ to cell survival in different lesions types 427	
as immortalized cell lines were used, however given the similarity observed in the in vitro 428	
results to the clinical samples we can be confident that IKKβ has a role in epithelial 429	
endometriotic cells. 430	
 431	
In conclusion we have observed a significant relationship between TNFα and the activation of 432	
IKKβ complex in the endometriotic microenvironment and that this activation occurs 433	
predominantly in the epithelial cells of peritoneal and DIE lesions. Furthermore IKKβ 434	
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inhibition in vitro significantly influenced epithelial cell, but not stromal cell behaviour. The 435	
regulation of kinase signalling pathways is a significant, but under explored area of 436	
endometriosis pathogenesis and progression and may represent potential non-hormonal 437	
treatment targets for endometriosis (McKinnon et al., 2016). Given the ability of the 438	
extracellular inflammatory environment to influence IKKβ activity and its subsequent affect 439	
on downstream pathways this kinase may be significant interest in endometriosis. 440	
 441	
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 587	588	
Table 1; Comparison of endometriotic lesion and peritoneal fluid protein expression in 589	
samples removed from women using different hormonal treatment.  Data are Mean ± 590	
SEM  591	
 Hormone treatment  
No hormone 
(n=14) 
Combined oral 
contraceptive 
(n = 4) 
GnRH 
analogue 
(n=3) 
Total 
(n =21) p 
pIKKα/β (%) 66 ± 9.8 77 ± 27.8 92 ± 17.5 72 ± 8.5 0.4732 
IKKβ (%) 120 ± 23.5 90 ±27.7 151 ± 27.7 119 ± 16.9 0.3819 
TNFα (pg/ml) 2.1 ± 0.61 1.2 ± 0.53 1.5 ± 0.54 1.9± 0.43 0.7721 
-IKKβ and pIKKα/β protein values were determined via Semi-quantitative Western blot 592	
densitometry analysis and expressed as a percentage of a standardised control sample 593	
included in each Western blot, as described in detail in the methods section.  594	
-TNFα values represent peritoneal fluid TNFα concentrations determined by ELISA and 595	
expressed as pg/ml. 596	
-Analysis of significance was performed via the non-parametric One-way ANOVA test 597	
(Kruskal-Wallis) and a post hoc comparison of all groups (Dunn’s multiple comparison test) 598	
significance p < .05 599	
  600	
  601	
Table II: Comparison of protein expression in formalin fixed paraffin embedded 602	
endometriotic tissue according to hormonal treatment.  Data are mean ± SEM  603	
Hormonal use 
No hormone 
(n= 6) 
Combined oral 
contraceptive 
(n = 5) 
GnRH analogue 
(n=5) 
Total 
(n =16) *P 
pIKKα/β 
     
  Epithelial 1.7 ± 0.56 3.4 ± 1.78 6.2 ± 2.27 3.6 ± 0.98 0.108 
  Stromal 0.3 ± 0.33 0.8 ± 0.37 0.6 ± 0.60 0.5 ± 0.24 0.448 
IKKβ 
     
  Epithelial 2.3 ± 0.95 2.2 ± 1.11 3.0 ± 1.76 2.5 ± 0.70 
0.949 
  Stromal 0.7 ± 0.42 12.4 ± 1.75 0.0 ± 0.00 1.00 ± 0.58 0.327 
-Values represent the scores derived from the semi-quantitative IHC analysis, described in 604	
detail in the methods. 605	
-Analysis of significance was performed via the non-parametric One-way ANOVA test 606	
(Kruskal-Wallis) and a post hoc comparison of all groups (Dunn’s multiple comparison test) 607	
significance p < .05 608	
  609	
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 611	
  612	
Figure 1; IKKβ activation in endometriosis and its relationship to tumor necrosis factor 613	
(TNF)α. (A) A significant correlation (r = 0.6268, n = 21, p = 0.0024) was present between 614	
the peritoneal fluid TNFα expression and the pIKKα/β(176/180) protein complex in 615	
endometriotic lesions. (B) No significant association was observed between the expression of 616	
endometriotic lesion IKKβ and peritoneal fluid TNFα expression. (C) Western blot analysis 617	
of endometriotic tissue samples confirmed a consistent presence of both IKKβ. In contrast the 618	
expression of pIKKα/β varied significantly amongst samples. Actinβ was used as a loading 619	
control. (D) Analysis of pIKKα/β expression indicated that high concentrations were 620	
identified in the peritoneal and DIE lesions with lower concentrations observed in the ovarian 621	
lesions. (E) Basal IKK was more uniform amongst all samples, although with a slightly 622	
lower, but non-significant expression in the DIE lesions. (F) Analysis of the pIKKα/β: IKKβ 623	
ratio confirmed a lower ratio of activation in the ovarian lesions that was significantly lower 624	
than that observed in DIE lesions. Protein concentration in all components was calculated as 625	
relative to the calibrator sample and expressed as a percentage. Correlation was determined 626	
performed by Spearman’s Rank correlation coefficient and comparison between lesion 627	
location performed by a non-parametric Kruskal-Wallis One-Way anaylsis (ANOVA) test 628	
with a post-hoc Dunn’s multiple comparison. * p < 0.05. (P) peritoneal, (O) ovarian and DIE 629	
(deeply infiltrating endometriosis. 630	
 631	
632	
Figure 2; Cell specific expression and activation of IKKβ in endometriotic lesions. Basal 633	
IKKβ expression was observed in both epithelial (black arrows) and stromal cells (red 634	
arrows) of endometriotic lesions removed from the (A) peritoneal, (B) ovarian, and (C) DIE 635	
regions. The expression of the activated IKK complex (pIKKα/β) was limited predominantly 636	
to the epithelial cells (black arrows), although some stromal cell expression was observed 637	
(red arrows). This was consistent across lesions from the (D) peritoneal, (E) ovarian and (F) 638	
and DIE lesions. Negative controls showed no expression in lesions from the (G) peritoneal 639	
(H) ovarian, or (I) DIE region. A semi-quantitative analysis of the cell specific expression 640	
indicated that no statistically significant variation in (J) IKKβ expression was observed 641	
between epithelial and stromal cells, however pIKKα/β was significantly stronger in the 642	
epithelial cells for all lesions with a largest difference observed in the DIE lesions. (K) 643	
Analysis of protein activation and expression between cell type and lesion location was 644	
performed with a Two-way analysis of variance (ANOVA) test with a post-hoc Tukey’s 645	
multiple comparison. Scale bars = 50µm. * p < 0.05 646	
  647	
 648	
 649	
Figure 3; pIKKα/β after tumor necrosis factor (TNF)α treatment in endometriotic 650	
epithelial cells. (A) Western blot analysis confirmed the expression of pIKKα/β in the 12Z, 651	
EM E6/E7 and EM ‘osis cell lines both with and without TNFα treatment. (B) Semi-652	
quantitative analysis indicated TNFα did not significantly influence either 12Z, or EM E6/E7 653	
expression. There was however a significant increase in pIKKα/β after both 10ng/ml and 654	
100ng/ml TNFα in the EM’osis cell line. 655	
  656	
 657	
 658	
Figure 4; Influence of IKKβ inhibition on epithelial and stromal cell viability. (A) 659	
Inhibition of IKKβ activity with increasing concentrations of PS1145 had no influence on the 660	
eutopic derived epithelial EM E6’E7 cells, significantly increased the cell viability of the 661	
ovarian derived EM’osis cells, significantly reduced the viability of the peritoneal derived 662	
12Z cells. (B) PS1145 had no influence on stromal cells from women with and without 663	
endometriosis.  Analysis on the influence between cell type and PS1145 concentrations on 664	
cell viability performed with a Two-way analysis of variance (ANOVA) test with a post-hoc 665	
Tukey’s multiple comparison test. ** p < 0.01, *** p < 0.001, **** p < 0.0001. 666	
 667	
668	
Figure 5; The IKK complex and its influence on downstream signalling pathways. 669	
Binding of extracellular tumor necrosis factor (TNF)α to TNF receptor 1 (TNFR1) stimulates 670	
the phosphorylation and activation of IKKα and IKKβ that exist as a complex along with 671	
IKKγ. Activation of IKKβ leads to the phosphorylation of IκBα, which under basal conditions 672	
is bound to the p65 subunit of the NFκB complex. Phosphorylation of IκBα removes it from 673	
the NFκB complex and initiates protesomal degradation allowing NFκB translocation into the 674	
nucleus and gene transcription. Activation of the IKK complex can also lead to an interaction 675	
with the tuberous sclerosis (TSC)2 protein that exists in a heterodimer with TSC1. Inhibition 676	
of TSC2 activity increases the activity of the mammalian target of rapamycin (mTOR) 677	
complex stimulating both protein translation and cellular proliferation. Activation of the IKK 678	
complex also leads to an inactivation of the BH3 only BAD protein inactivating TNFα 679	
stimulated apoptosis. 680	
 681	
